|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
50680234
???header.onlineuser??? :
398
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"ryoo"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立成功大學 |
2024-01-20 |
Coformulated quavonlimab and pembrolizumab (pembro) in combination with lenvatinib (lenva) as first-line (1L) therapy for patients (pts) with advanced hepatocellular carcinoma (HCC): Phase 2 KEYSTEP-004 study.
|
Rimassa;Lorenza;Li;Daneng;Ikeda;Masafumi;Yarchoan;Mark;Ryoo;Baek-Yeol;Kossler;Thibaud;Lim;Ho-Yeong;Kwiatkowski;Mariusz;Chang;Ting-Tsung;Kim;Hyun, Jee;Casadei-Gardini;Andrea;Kudo;Masatoshi;Ren;Zhenggang;Calvo;Varela, Maria;Llovet;Josep, M.;Zhang;Yayan;Hatogai;Ken;Siegel;Abby, B.;Cheng;Ann-Lii |
| 國立成功大學 |
2024-01-2 |
Association between Conversion to Shockable Rhythms and Survival with Favorable Neurological Outcomes for Out-of-Hospital Cardiac Arrests
|
Ho;Wah, Andrew Fu;Lee;Yi, Kai;Nur;Shahidah;Fook;Chong, Stephanie;Pek;Pin, Pin;Tanaka;Hideharu;Sang;Shin, Do;Chow;Patrick, In-Ko;Tan;Benjamin, Yong-Qiang;Lim;Lynn, Shir;Ma;Matthew, Huei-Ming;Ryoo;Wook, Hyun;Lin;Chih-Hao;Kuo;Chan-Wei;Kajino;Kentaro;Ong;Hock, Marcus Eng |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
